Lymph-node Epstein-Barr virus concentration in diagnosing cervical lymph-node metastasis in nasopharyngeal carcinoma

被引:5
作者
Li, HuiFang [1 ]
Huang, Can [1 ,2 ]
Chen, Qiuyan [3 ]
Peng, Chuan [1 ]
Zhang, Rong [4 ]
Shen, Jingxian [4 ]
Chen, Mingyuan [3 ]
Mai, Haiqiang [3 ]
Zou, Ruhai [1 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Ultrasound, Guangzhou 510060, Guangdong, Peoples R China
[2] Kanghua Hosp, Dongguan 523039, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiol, Guangzhou 510060, Guangdong, Peoples R China
关键词
Lymph-node metastasis; Epstein-Barr virus; Nasopharyngeal carcinoma; Cervical lymph-node metastasis; Fine-needle aspiration; FINE-NEEDLE-ASPIRATION; MODULATED RADIATION-THERAPY; STAGING SYSTEM; DNA; CYTOLOGY; LYMPHADENOPATHY; RADIOTHERAPY; DELINEATION; TOMOGRAPHY; GUIDELINE;
D O I
10.1007/s00405-020-05937-5
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose Cervical lymph-node (CLN) metastasis commonly occurs in patients with nasopharyngeal carcinoma (NPC) metastasis. The presence of Epstein-Barr virus (EBV) genomes in neck lymph nodes may diagnose CLN. This research was designed to appraise the diagnostic value of EBV concentration for cervical lymph nodes in NPC. Methods Two hundred and fifty-three NPC patients with 276 CLNs were enrolled. MRI was performed to detect CLN metastasis, and plasma EBV concentration was measured by quantitative PCR before treatment. Ultrasonography (US) and US-FNA were subsequently performed in the suspicious lymph nodes. Fifteen patients (22 lymph nodes) underwent fine-needle aspiration cytology (FNAC), and the remaining 242 patients (254 lymph nodes) underwent core needle biopsy (CNB) for CLNs at the clinician's demand. The aspiration needle was rinsed with 1 ml of normal saline for EBV detection. The method of lymph-node EBV measurement was consistent with that for plasma. The MRI results and EBV concentrations in plasma and lymph nodes were recorded and analyzed. Plasma EBV concentrations >= 4000 copies/ml were regarded as positive. Results CLN-EBV concentrations >= 787.5 copies/ml were regarded as positive according to receiver-operating characteristic curve analysis. The AUC of the EBV (0.925) concentration in CLN metastasis was significantly larger than the AUC of MRI (0.714) (P < 0.001). The sensitivity and specificity were 94.09% and 48.72% for MRI in lymph-node metastasis and 95.36% (P > 0.05) and 84.62% (P < 0.01) for EBV DNA in CLN metastasis, respectively. The sensitivity and specificity of EBV in plasma were 77.2% and 71.8%, respectively. The diagnostic specificity and AUC of EBV in CLNs were higher than those of MRI and plasma EBV (P < 0.005). Conclusions Ultrasound-guided CLN FNA to obtain EBV concentrations may provide a new method to diagnose CLN metastasis with high sensitivity and specificity.
引用
收藏
页码:2513 / 2520
页数:8
相关论文
共 44 条
  • [1] Commutability of the Epstein-Barr Virus WHO International Standard across Two Quantitative PCR Methods
    Abeynayake, Janaki
    Johnson, Ryan
    Libiran, Paolo
    Sahoo, Malaya K.
    Cao, Hongbin
    Bowen, Raffick
    Chan, K. C. Allen
    Quynh-Thu Le
    Pinsky, Benjamin A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (10) : 3802 - 3804
  • [2] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
    Amin, Mahul B.
    Greene, Frederick L.
    Edge, Stephen B.
    Compton, Carolyn C.
    Gershenwald, Jeffrey E.
    Brookland, Robert K.
    Meyer, Laura
    Gress, Donna M.
    Byrd, David R.
    Winchester, David P.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 93 - 99
  • [3] Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614
  • [4] Non-nasopharyngeal head and neck lymphoepithelioma-like carcinoma in the United States: A population-based study
    Chan, Jason Y. K.
    Wong, Eddy W. Y.
    Ng, Siu-Kwan
    Vlantis, Alexander C.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1294 - E1300
  • [5] Efficacy of fine-needle aspiration in diagnosing cervical nodal metastasis from nasopharyngeal carcinoma after radiotherapy
    Chan, Jimmy Yu Wai
    Chan, Richie Chiu Lung
    Chow, Velda Ling Yu
    To, Victor Shing Howe
    Wei, William Ignace
    [J]. LARYNGOSCOPE, 2013, 123 (01) : 134 - 139
  • [6] Chan KCA, 2017, NEW ENGL J MED, V377, P513, DOI [10.1056/NEJMoa1701717, 10.1056/nejmoa1701717]
  • [7] The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
    Edge, Stephen B.
    Compton, Carolyn C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) : 1471 - 1474
  • [8] DIAGNOSIS OF NASOPHARYNGEAL CARCINOMA BY DNA AMPLIFICATION OF TISSUE OBTAINED BY FINE-NEEDLE ASPIRATION
    FEINMESSER, R
    MIYAZAKI, I
    CHEUNG, R
    FREEMAN, JL
    NOYEK, AM
    DOSCH, HM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (01) : 17 - 21
  • [9] Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
    Gregoire, Vincent
    Ang, Kian
    Budach, Wilfried
    Grau, Cai
    Hamoir, Marc
    Langendijk, Johannes A.
    Lee, Anne
    Quynh-Thu Le
    Maingon, Philippe
    Nutting, Chris
    O'Sullivan, Brian
    Porceddu, Sandro V.
    Lengele, Benoit
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 110 (01) : 172 - 181
  • [10] Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma
    Guo, Rui
    Tang, Ling-Long
    Mao, Yan-Ping
    Du, Xiao-Jing
    Chen, Lei
    Zhang, Zi-Chen
    Liu, Li-Zhi
    Tian, Li
    Luo, Xiao-Tong
    Xie, Yu-Bin
    Ren, Jian
    Sun, Ying
    Ma, Jun
    [J]. CANCER, 2019, 125 (01) : 79 - 89